Telomerase activity in myelodysplastic syndrome

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Telomerase activity (TA) plays a crucial role in cellular immortalization and is implicated in various cancers.
• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and a high risk of transformation to acute myeloid leukemia.

Purpose of the Study:

• To investigate and compare telomerase activity (TA) in bone marrow mononuclear cells across different stages of myelodysplastic syndrome (MDS).
• To establish a comparative analysis of TA between MDS patients, normal bone marrow cells, and leukemic cells.

Main Methods:

• Semi-quantitative determination of TA using a polymerase chain reaction-enzyme linked immuno-sorbent assay (PCR-ELISA) kit.
• Analysis of mononuclear cells from 20 normal bone marrow samples, 21 MDS patients, and 32 acute leukemia cases.

Main Results:

• Normal bone marrow cells exhibited low TA (mean 0.11 U), while acute leukemia cells showed significantly higher TA (mean 0.42 U, P < 0.01).
• MDS patients displayed moderate TA (mean 0.27 U), significantly higher than normal controls (P < 0.05).
• High-risk MDS subgroups, stratified by the International Prognostic Scoring System (IPPS), demonstrated significantly elevated TA compared to lower-risk groups (P < 0.05).

Conclusions:

• Telomerase activity is marginally present in normal bone marrow but markedly increased in acute leukemia.
• MDS patients exhibit moderate TA, with significantly higher levels observed in high-risk subgroups, suggesting TA as a potential prognostic marker.